Nature Communications (Jan 2019)

SREBP-dependent lipidomic reprogramming as a broad-spectrum antiviral target

  • Shuofeng Yuan,
  • Hin Chu,
  • Jasper Fuk-Woo Chan,
  • Zi-Wei Ye,
  • Lei Wen,
  • Bingpeng Yan,
  • Pok-Man Lai,
  • Kah-Meng Tee,
  • Jingjing Huang,
  • Dongdong Chen,
  • Cun Li,
  • Xiaoyu Zhao,
  • Dong Yang,
  • Man Chun Chiu,
  • Cyril Yip,
  • Vincent Kwok-Man Poon,
  • Chris Chung-Sing Chan,
  • Kong-Hung Sze,
  • Jie Zhou,
  • Ivy Hau-Yee Chan,
  • Kin-Hang Kok,
  • Kelvin Kai-Wang To,
  • Richard Yi-Tsun Kao,
  • Johnson Yiu-Nam Lau,
  • Dong-Yan Jin,
  • Stanley Perlman,
  • Kwok-Yung Yuen

DOI
https://doi.org/10.1038/s41467-018-08015-x
Journal volume & issue
Vol. 10, no. 1
pp. 1 – 15

Abstract

Read online

Viruses rely on host cell metabolism for replication, making these pathways potential therapeutic targets. Here, the authors show that AM580, a retinoid derivative and RAR-α agonist, affects replication of several RNA viruses by interfering with the activity of SREBP.